(TIVC) Tivic Health Systems, Inc. Marketing Mix Research |
Fully Editable: Tailor To Your Needs In Excel Or Sheets
Professional Design: Trusted, Industry-Standard Templates
Investor-Approved Valuation Models
MAC/PC Compatible, Fully Unlocked
No Expertise Is Needed; Easy To Follow
(TIVC) Tivic Health Systems, Inc. Complete Analysis Pack
Unlock Strategic Clarity
This Tivic Health Systems, Inc. 4P's Marketing Mix Analysis explains the product (medical neurostimulation devices), its use (treatment of sinus and nasal inflammation), and shows how Price, Place, and Promotion support uptake; the page contains a real preview/sample of the report so you can assess style and substance—purchase the full version for the complete ready-to-use analysis.
Product
ClearUP sinus device
ClearUP is Tivic Health Systems, Inc.'s flagship consumer medical device, built for at-home relief of sinus and nasal inflammation. It uses targeted microcurrent therapy and is positioned as a non-drug option in a U.S. sinus-care market that tops $1 billion in OTC sales. Tivic has kept the product central to its consumer mix, aiming at people who want fast, self-use relief without a prescription.
Bioelectronic technology
Tivic Health Systems, Inc. sells bioelectronic devices, not drug therapies, so its 4P product mix centers on neuromodulation-based symptom relief. Its platform targets nerve signals with electrical stimulation, which can set it apart from traditional pharmaceutical brands that rely on chemical compounds. That non-drug angle gives Tivic a clear device-first position in a market where faster, localized relief can matter.
Non-invasive treatment
Tivic Health Systems, Inc. centers this product on non-invasive neuromodulation, so users can avoid pills, needles, and surgery. That convenience-first design is the core value proposition and fits patients who want lower-friction care. In 2025, that kind of no-procedure treatment choice matters more as consumers compare faster, simpler options across healthcare.
Inflammation management focus
Tivic Health Systems, Inc. keeps ClearUP tightly focused on sinus and nasal inflammation, not broad pain relief. ClearUP uses microcurrent to target sinus pressure and congestion, a narrow clinical use case that fits patients with recurring upper-airway symptoms. The company’s 2024 annual report showed revenue of $1.7 million, underscoring how small and specialized this market still is.
- Targets sinus and nasal inflammation
- Relieves pressure and congestion
- Clinically narrow use case
At-home consumer use
ClearUP is positioned as a consumer health device for at-home use, not a clinic-only tool. That fits a direct-purchase model, where customers can buy it online and use it repeatedly for personal sinus relief. Tivic Health Systems, Inc. also benefits from lower service friction, since home use supports routine, repeat demand.
- Consumer device, not clinical-only
- Supports direct-to-consumer sales
- Built for repeat at-home use
- Lower purchase friction than clinic care
ClearUP: Tivic Health’s Core Sinus Relief Device Is Still Early-Stage
ClearUP is Tivic Health Systems, Inc.'s core product: a non-drug, at-home microcurrent device for sinus pressure and congestion. It stays focused on a narrow use case, which supports direct-to-consumer sales and repeat home use. Tivic Health Systems, Inc. reported $1.7 million revenue in 2024, showing the product is still early-stage.
| Metric | Value |
|---|---|
| Product | ClearUP |
| Use | Sinus relief |
| Mode | Microcurrent |
| Revenue | $1.7 million |
What is included in the product
Detailed Word Document
Delivers a concise, company-specific 4P analysis of Tivic Health Systems, Inc.’s Product, Price, Place, and Promotion strategy.
Editable Excel File
Condenses Tivic Health’s 4Ps into a quick, pain-point-relieving snapshot for fast strategic review.
Reference Sources
Provides a concise, traceable bibliography of primary industry reports, clinical studies, company filings, and market datasets to validate Tivic Health Systems’ market, pricing, and unit-economics assumptions.
Place
Company website
Tivic Health Systems sells direct on its own website, so it controls product details, pricing, and checkout end to end. That direct-to-consumer model keeps the customer relationship in-house and avoids retail markups. For a small-revenue company, every online visit and conversion matters.
Amazon.com
Amazon.com gives Tivic Health Systems, Inc. access to a huge national e-commerce audience, since Amazon served over 300 million active customer accounts worldwide and generated about $638 billion in net sales in 2024. That reach can lift search visibility, improve purchase convenience, and help the Company sell where buyers already shop.
Walmart.com
Tivic Health Systems, Inc. sells products on Walmart.com, putting the brand inside Walmart’s mass-market digital reach. Walmart reported FY2025 revenue of $681.0 billion, so this channel gives Tivic far more exposure than its own site alone. It also helps capture shoppers already comparing health products online.
BestBuy.com
Tivic Health Systems, Inc. also sells on BestBuy.com, adding a major U.S. retailer with Best Buy Co., Inc. FY2025 net sales of $41.5 billion. That channel can lift reach and trust, because BestBuy.com gives Tivic access to millions of active shoppers in a familiar marketplace.
- Trusted U.S. online retail channel
- Expands consumer access fast
- Supports brand credibility
FSAStore.com
Tivic Health Systems, Inc. uses FSAStore.com as a sales channel for shoppers seeking eligible health purchases. It fits buyers who want to use pre-tax FSA and HSA funds, which makes checkout easier and can lift conversion on qualified items. This channel also broadens reach beyond direct sales by meeting demand where benefit-linked shopping starts.
- Reaches FSA and HSA shoppers
- Supports pre-tax purchase convenience
Tivic’s Multi-Channel Reach Drives U.S. Sales Access
Tivic Health Systems, Inc. uses a place mix centered on direct online sales plus Amazon, Walmart.com, BestBuy.com, and FSAStore.com, giving it broad U.S. reach without store buildout. Amazon reported 2024 net sales of about $638 billion, Walmart FY2025 revenue was $681.0 billion, and Best Buy Co., Inc. FY2025 net sales were $41.5 billion. The channel mix improves access, trust, and checkout convenience.
| Channel | 2025/2024 scale | Role |
|---|---|---|
| Own site | N/A | Direct control |
| Amazon | $638B net sales | Mass reach |
| Walmart.com | $681.0B revenue | Broad exposure |
| BestBuy.com | $41.5B net sales | Trust and traffic |
Preview the Actual Deliverable
Tivic Health Systems, Inc. Reference Sources
The preview shown here is the actual Tivic Health Systems, Inc. 4P's Marketing Mix document you’ll receive instantly after purchase—no surprises; it’s fully complete, editable, and ready to use for strategy, presentations, or investor review.
Promotion
Direct-to-consumer online selling
Tivic Health Systems, Inc. uses direct-to-consumer online selling as a direct-response channel, with its website doing the heavy lift of explaining the product and pushing shoppers to buy. This matters because the site can answer questions fast, build trust, and turn search traffic into sales without a middleman. For Tivic Health Systems, Inc., promotion and e-commerce are tightly linked, so every click can be tracked against conversion.
Marketplace merchandising
Tivic Health Systems, Inc. uses 4 marketplaces—Amazon, Walmart, Best Buy, and FSAStore—as promotion, turning search results into shelf space. Their product pages, ratings, and reviews create point-of-purchase awareness, where buying intent is highest. With 4 listings, the brand can reach buyers across general retail and HSA/FSA channels at the same time.
Medical-device positioning
Tivic Health Systems, Inc. positions ClearUP as a medical device for sinus relief and inflammation management, not a wellness gadget. The message leans on non-invasive, at-home use, which supports use in a care setting and makes the product feel clinically oriented. That positioning helps it sit closer to health solutions than lifestyle products.
Public-company communications
Tivic Health Systems, Inc. can use press releases and SEC-style investor updates to raise brand awareness, support market visibility, and explain product and business news fast. For a public company, this channel matters because it turns filings and updates into plain-language messages that can reach investors, media, and customers at the same time.
- Press releases widen reach quickly
- Investor notes explain product changes
- Public updates support trust and visibility
This is especially useful when Tivic Health Systems, Inc. needs to share launch progress, clinical news, or financial results, since clear disclosure can shape how the market reads each update.
Digital consumer reach
Tivic Health Systems, Inc. leans on digital consumer reach because its online distribution depends on search, retailer pages, and web-based education to drive discovery. That fits a low-friction consumer health path, where buyers can learn, compare, and purchase without a long sales cycle.
For consumer devices like ClearUP, digital promotion matters because trust and product clarity can move conversion more than broad brand ads. Online education also helps explain use cases and benefits at the point of search.
- Search drives first discovery
- Retail pages support conversion
- Web education lowers purchase friction
Tivic Health’s Direct-to-Consumer Push Spans 4 Key Marketplaces
Tivic Health Systems, Inc. promotes ClearUP mainly through direct-to-consumer digital channels, so search, product pages, and its own site do the selling. It also uses 4 marketplaces—Amazon, Walmart, Best Buy, and FSAStore—to widen reach and capture buyers at the point of intent. Press releases and investor updates help turn product news into trust and visibility.
| Promotion lever | Data |
|---|---|
| Marketplaces | 4 |
| Core channel | Direct-to-consumer |
| Messaging | Medical device focus |
Price
Retail checkout pricing
ClearUP is sold as a consumer device through online retail channels, so the price is set at checkout on the website or marketplace. That makes Tivic Health Systems, Inc. pricing visible and easy to compare, which can push buyers to shop on price. In online retail, this also means discounts and promos can change demand fast.
Channel-specific pricing
Tivic Health Systems, Inc. can use channel-specific pricing because prices may differ across retailers and direct listings. On marketplaces, rival offers and promo codes can push prices lower, while other channels may hold a higher list price. That gives Tivic Health Systems, Inc. a flexible pricing structure tied to channel demand.
One-time purchase model
Tivic Health Systems, Inc. uses a one-time purchase model for its device, so customers usually pay once instead of facing recurring prescription or subscription fees. That keeps buying simple and lowers long-term cost anxiety. For the company, this means revenue is tied to unit sales, not monthly renewals, so volume matters more than repeat billing.
Pre-tax spending options
Tivic Health Systems, Inc.’s FSAStore.com availability can help buyers use pre-tax FSA or HSA funds, which may cut the out-of-pocket cost of eligible purchases. For 2025, the IRS set HSA limits at $4,300 for self-only coverage and $8,550 for family coverage, with a $3,300 health FSA limit, so the tax benefit can be material.
- Pre-tax funds lower net cost.
- Eligible buyers face less cash strain.
- Supports health-account spending.
Value-based positioning
Tivic Health Systems, Inc. prices on value, not on drug cost: its non-invasive sinus relief is sold for home use and convenience. That fits a consumer-health model where buyers pay for utility, fewer repeat purchases, and avoiding prescription-like treatment paths.
One simple read: the price has to look fair versus recurring OTC spending and the ease of using ClearUP at home.
- Non-invasive relief drives willingness to pay
- Home use supports utility-based pricing
- Competes on convenience, not drugs
ClearUP Pricing Hinges on One-Time Value, Not Subscriptions
Tivic Health Systems, Inc. prices ClearUP as a one-time consumer purchase, so demand is sensitive to checkout price, promo cuts, and marketplace comparison. FSAStore.com access can lower net cost for eligible buyers; for 2025, HSA limits are $4,300 self-only and $8,550 family, and the health FSA limit is $3,300. So price is built around convenience and perceived value, not recurring billing.
| Price driver | 2025 data |
|---|---|
| HSA self-only | $4,300 |
| HSA family | $8,550 |
| Health FSA | $3,300 |
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.